trending Market Intelligence /marketintelligence/en/news-insights/trending/UlJhBTBPWHXWL83aqg448w2 content esgSubNav
In This List

OncoSec Medical prices $11M common stock, warrants offering

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


OncoSec Medical prices $11M common stock, warrants offering

OncoSec Medical Inc. priced a public offering of common stock and warrants to raise about $11 million in gross proceeds.

The Pennington, N.J.-based cancer drug developer is selling 3,492,063 common shares together with warrants to buy up to 2,619,047 common shares at a combined price of $3.15. The five-year warrants are exercisable at $3.45 apiece upon issuance.

The company also granted the underwriter a 45-day option to buy additional common shares or warrants to cover overallotments.

OncoSec expects gross proceeds of about $11 million from the offering, which is expected to close May 24.

A.G.P./Alliance Global Partners is acting as sole book-running manager for the offering.